HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor activity of iNGR-GRIM-19 in colorectal cancer.

AbstractBACKGROUND:
Gene associated with retinoid-interferon induced mortality-19 (GRIM-19) plays crucial roles in carcinogenesis.
OBJECTIVE:
To explore the antitumor activity of internalizing NGR (iNGR) gene associated with GRIM-19 in colorectal cancer.
METHODS:
Cells were incubated with fluorescein isothiocyanate-labeled fusion proteins followed by fluorescence microscopic analysis. Cell proliferation was determined by MTT assay. Cell cycle was analyzed by flow cytometric analysis. Cell migration and invasion capacity were evaluated by wound scratch and Transwell assays, respectively. Apoptosis was measured by Annexin V/PI staining and TUNEL assay. Gene expressions were determined by RT-PCR and Western blotting. Nude mice bearing colorectal cancer received vehicle, GRIM-19, or iNGR-GRIM-19 fusion protein injection, and the in vivo antitumor capacity of the fusion proteins was examined.
RESULTS:
iNGR-GRIM-19 was specifically taken up by human colorectal cancer Colo205 cells, but not corneal epithelial (HCEpic) cells, whereas GRIM-19 was not internalized by either cell type. Unlike GRIM-19, incubation with iNGR-GRIM-19 dose-dependently inhibited proliferation, induced G1 phase arrest, suppressed cell migration and invasion, and caused apoptosis in Colo205 cells. Additionally, injection of iNGR-GRIM-19 extended the lifespan of colorectal cancer-bearing nude mice and reduced in vivo tumor growth as compared with vehicle or GRIM-19 treatment. iNGR-GRIM-19 was localized only in the tumor mass, without affecting other tissues, such as liver or kidney. iNGR-GRIM-19 injection led to G1 phase arrest and induced cell apoptosis in xenografted colorectal cancer tissues.
CONCLUSIONS:
iNGR-GRIM-19 has an efficient antitumor activity in vitro and in vivo, and might be a promising agent for the treatment of colorectal cancer.
AuthorsLi Pang, Yan Xia, Dawei Wang, Xiangwei Meng
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 47 Issue 9 Pg. 795-808 (Sep 01 2017) ISSN: 1465-3621 [Electronic] England
PMID28903530 (Publication Type: Journal Article)
Copyright© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: [email protected].
Chemical References
  • NADH, NADPH Oxidoreductases
  • Grim19 protein, mouse
Topics
  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Colorectal Neoplasms (drug therapy, pathology)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • NADH, NADPH Oxidoreductases (therapeutic use)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: